![]() ![]() ![]() Licensed by the Food and Drug Administration (FDA). To date, only one commercial Western blot test (Du PontPr) has More specific test, the most common of which is the Western blot ![]() In the EIA for HIV-1 antibody are then retested with a supplemental Seroprevalence surveys, and for blood-donor screening.Įnzyme immunoassay (EIA) is the most widely used serologic testĭetecting antibody to HIV-1. Including clinical diagnosis of HIV-1 infection-for symptomaticĪsymptomatic patients in counseling and testing programs-for These tests have been used for various purposes, Retrovirus was identified as the cause of acquired immunodeficiency Immunodeficiency virus type 1 (HIV-1) progressed rapidly after this The development of sensitive and specific tests for antibody to Reach an accurate diagnosis for persons tested for HIV-1 infection. Health policy officials with useful information in their efforts to Which to report results in order to provide clinicians and public Provides recommendations for use of the Western blot and the manner Specificity of these criteria as tools for public health practice, With the Western blot test for HIV-1, evaluates the sensitivity and It includes a description of various interpretive criteria The Association of State and Territorial Public Health Laboratoryĭirectors (ASTPHLD) and CDC have collaborated in preparing this Public Health Practice Program Office, Centers for Disease Control* Laboratory Directors and AIDS Program, Center for Infectious Reported by: Association of State and Territorial Public Health Please note: This guideline document is obsolete and may not reflect current evidence or best practice and likely contains out-of-date information. Interpretation and Use of the Western Blot Assayįor Serodiagnosis of Human Immunodeficiency Virus Type 1 Infections For assistance, please send e-mail to: Type 508 Accommodation and the title of the report in the subject line of e-mail. Contact the University of Washington Clinical Virology Lab (206 685-8037) for ordering instructions.Persons using assistive technology might not be able to fully access information in this file. CSF antibody testing will be performed ONLY when paired with a serum sample. For accurate seroconversion determination, the acute and convalescent samples should be drawn at least 12 -16 weeks apart.įor CSF, see HSV SemiQnt Rapid PCR, Swab/CSF (Herpes Simplex Virus by PCR). It has not been cleared or approved by the US Food and Drug Administration.įor Paired samples, see Herpes Simplex Seroconversion Panel by Western Blot (Paired) for seroconversion on paired serum samples. This test was developed and its performance characteristics determined by the University of Washington Department of Laboratory Medicine and Pathology.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |